Granata, A., Maccarrone, R., Anzaldi, M., Leonardi, G., Pesce, F., Amico, F., Gesualdo, L., & Corrao, S
coli, K
This has made both diabetes and obesity key health priorities globally
Both started as diabetes medications Jardiance and Ozempic were both originally developed to manage type 2 diabetes , not weight loss
Therefore, in this systematic review, it was aimed to analyze the studies on GLP-1 and reward, establish a comprehensive framework on the reward-related effects of GLP-1, and answer its potential use for targeting reward system related pathologies
The United States leads due to a large aging population seeking cognitive and metabolic health solutions, supported by a mature regulatory environment that facilitates product innovation and marketing